Treatment for sickle cell disease, the most common inherited blood disorder in Kenya, has been approved for use in England for older children and adults with a severe form of the disease.The treatment ...
In this article, we explore the experiences of sickle cell patients in emergency care and the ways they can advocate for themselves ...
NHS approves £1.65m gene therapy for sickle cell disease, offering a potential cure. A milestone for patients, especially in ...
January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.
In this video, Sham Mailankody, MBBS discusses the current state of the pipeline for developing multiple myeloma treatments.
News Medical on MSN2h
SAB BIO announces positive topline Phase 1 clinical results with potentially disease-modifying T1D therapy SAB-142SAB BIO, (“SAB BIO”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback